Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 23605805)

1.

Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.

Wang Y, Wang Z, Zuo Z, Tomlinson B, Lee BT, Bolger MB, Chow MS.

AAPS J. 2013 Jul;15(3):787-96. doi: 10.1208/s12248-013-9479-1. Epub 2013 Apr 19.

2.

Improving sublingual delivery of weak base compounds using pH(max) concept: application to propranolol.

Wang Y, Zuo Z, Chen X, Tomlinson B, Chow MS.

Eur J Pharm Sci. 2010 Feb 19;39(4):272-8. doi: 10.1016/j.ejps.2009.12.011. Epub 2010 Jan 8.

PMID:
20060467
3.

Development of a Novel Oral Cavity Compartmental Absorption and Transit Model for Sublingual Administration: Illustration with Zolpidem.

Xia B, Yang Z, Zhou H, Lukacova V, Zhu W, Milewski M, Kesisoglou F.

AAPS J. 2015 May;17(3):631-42. doi: 10.1208/s12248-015-9727-7. Epub 2015 Feb 26.

PMID:
25716146
4.

The effect of pH on the buccal and sublingual absorption of captopril.

McElnay JC, al-Furaih TA, Hughes CM, Scott MG, Elborn JS, Nicholls DP.

Eur J Clin Pharmacol. 1995;48(5):373-9.

PMID:
8641325
5.

In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.

Sjögren E, Westergren J, Grant I, Hanisch G, Lindfors L, Lennernäs H, Abrahamsson B, Tannergren C.

Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29.

PMID:
23727464
6.

Pharmacokinetic investigation of a nicotine sublingual tablet.

Molander L, Lunell E.

Eur J Clin Pharmacol. 2001 Jan-Feb;56(11):813-9.

PMID:
11294371
7.

A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.

Dali MM, Moench PA, Mathias NR, Stetsko PI, Heran CL, Smith RL.

J Pharm Sci. 2006 Jan;95(1):37-44.

PMID:
16307454
8.

Pharmacokinetics and pharmacodynamics of propranolol in hypertensive patients after sublingual administration: systemic availability.

Mansur AP, Avakian SD, Paula RS, Donzella H, Santos SR, Ramires JA.

Braz J Med Biol Res. 1998 May;31(5):691-6.

PMID:
9698776
10.

Decreased absorption as a possible cause for the lower bioavailability of a sustained-release propranolol.

Takahashi H, Ogata H, Warabioka R, Kashiwada K, Ohira M, Someya K.

J Pharm Sci. 1990 Mar;79(3):212-5.

PMID:
2338628
11.

Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core.

Mehuys E, Remon JP, Korst A, Van Bortel L, Mols R, Augustijns P, Porter C, Vervaet C.

J Control Release. 2005 Oct 20;107(3):523-36.

PMID:
16055224
12.

Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.

Parikh N, Goskonda V, Chavan A, Dillaha L.

Clin Drug Investig. 2013 Jun;33(6):391-400. doi: 10.1007/s40261-013-0079-8.

PMID:
23605506
13.

Bioavailability of propranolol hydrochloride tablet formulations: application of multiple dose crossover studies.

Eldon MA, Kinkel AW, Daniel JE, Latts JR.

Biopharm Drug Dispos. 1989 Jan-Feb;10(1):69-76.

PMID:
2923962
14.

Bioavailability of sustained release propranolol formulations.

McAinsh J, Baber NS, Holmes BF, Young J, Ellis SH.

Biopharm Drug Dispos. 1981 Jan-Mar;2(1):39-48.

PMID:
7236870
15.

Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.

Markowitz JS, Straughn AB, Patrick KS, DeVane CL, Pestreich L, Lee J, Wang Y, Muniz R.

Clin Pharmacokinet. 2003;42(4):393-401.

PMID:
12648029
16.

Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects.

Gerrits M, de Greef R, Peeters P.

Biopharm Drug Dispos. 2010 Jul;31(5-6):351-7. doi: 10.1002/bdd.718.

PMID:
20549835
17.
18.

A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) model.

Hénin E, Bergstrand M, Standing JF, Karlsson MO.

AAPS J. 2012 Jun;14(2):155-63. doi: 10.1208/s12248-012-9324-y.

19.

Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.

Parikh N, Goskonda V, Chavan A, Dillaha L.

Clin Ther. 2013 Mar;35(3):236-43. doi: 10.1016/j.clinthera.2013.02.017.

PMID:
23497761
20.

Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.

Greenblatt DJ, Harmatz JS, Roth T, Singh NN, Moline ML, Harris SC, Kapil RP.

Clin Ther. 2013 May;35(5):604-11. doi: 10.1016/j.clinthera.2013.03.007. Epub 2013 Mar 28. Erratum in: Clin Ther. 2013 Jun;35(6):900.

PMID:
23541711
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk